RxDoctor Payments Data

Monica Schwartzman

Rheumatology · New York, NYNPI 1912392531

Payments from drug & device makers

$176,566in general payments, 2019–2025

Across 270 payments — averaging $653.95 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$115K
  • UCB, Inc.$49K
  • Lilly USA, LLC$6K
  • AbbVie$2K
  • Biogen$1K
  • UCB SA$1K
  • plus $2K from 14 others

What the payments were for

  • Consulting fees$33,53619%
  • Speaking & faculty fees$110,25862%
  • Travel & lodging$25,72815%
  • Food & beverage$6,4124%
  • Other$6320%

General payments by program year

19
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$176,566 in reported general payments places this provider in the 85th percentile of 541 rheumatology providers in New York.

See all rheumatology providers in New York

Most prescribed under Part D

DrugClaimsCost to plans & patients
Methylprednisolone35$1,803
Hydroxychloroquine Sulfate21$899
Rosuvastatin Calcium12$217
Prednisone13$155

Paid to pharmacies, not to this prescriber.

Other rheumatology in New York

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →